

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 4.88218450 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.26572278 |
| 3 | complement activation, alternative pathway (GO:0006957) | 4.25520950 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.19404144 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.08078855 |
| 6 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.00948013 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.00572153 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.00572153 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.96773965 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 3.83472387 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.83472387 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.76487454 |
| 13 | protein carboxylation (GO:0018214) | 3.76487454 |
| 14 | T-helper 1 type immune response (GO:0042088) | 3.72587368 |
| 15 | urea metabolic process (GO:0019627) | 3.68854944 |
| 16 | urea cycle (GO:0000050) | 3.68854944 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67579015 |
| 18 | regulation of protein activation cascade (GO:2000257) | 3.63563617 |
| 19 | oligosaccharide catabolic process (GO:0009313) | 3.56510562 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 3.53577598 |
| 21 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.51839377 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.48279183 |
| 23 | regulation of complement activation (GO:0030449) | 3.45898728 |
| 24 | kynurenine metabolic process (GO:0070189) | 3.43966583 |
| 25 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.41866506 |
| 26 | bile acid biosynthetic process (GO:0006699) | 3.39889931 |
| 27 | nucleobase catabolic process (GO:0046113) | 3.39192504 |
| 28 | response to muramyl dipeptide (GO:0032495) | 3.39178708 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 3.37749914 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.37638881 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.36523010 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.36169438 |
| 33 | nerve growth factor signaling pathway (GO:0038180) | 3.36050960 |
| 34 | glycosphingolipid catabolic process (GO:0046479) | 3.33064596 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 3.28607310 |
| 36 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.25733892 |
| 37 | plasma lipoprotein particle clearance (GO:0034381) | 3.21382357 |
| 38 | locomotory exploration behavior (GO:0035641) | 3.18450426 |
| 39 | positive regulation of lipid catabolic process (GO:0050996) | 3.16611625 |
| 40 | regulation of mononuclear cell migration (GO:0071675) | 3.15788732 |
| 41 | germinal center formation (GO:0002467) | 3.15760951 |
| 42 | glutamate metabolic process (GO:0006536) | 3.15520163 |
| 43 | regulation of fibrinolysis (GO:0051917) | 3.15349875 |
| 44 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13361149 |
| 45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13361149 |
| 46 | modulation by symbiont of host immune response (GO:0052553) | 3.13361149 |
| 47 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13361149 |
| 48 | modulation by symbiont of host defense response (GO:0052031) | 3.13361149 |
| 49 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13361149 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.13256855 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.13256855 |
| 52 | indole-containing compound catabolic process (GO:0042436) | 3.13256855 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.11399467 |
| 54 | homocysteine metabolic process (GO:0050667) | 3.11331771 |
| 55 | phospholipid homeostasis (GO:0055091) | 3.10326795 |
| 56 | lysine catabolic process (GO:0006554) | 3.10121003 |
| 57 | lysine metabolic process (GO:0006553) | 3.10121003 |
| 58 | cysteine metabolic process (GO:0006534) | 3.09931400 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08486624 |
| 60 | glyoxylate metabolic process (GO:0046487) | 3.08206773 |
| 61 | reverse cholesterol transport (GO:0043691) | 3.07727295 |
| 62 | sulfur amino acid catabolic process (GO:0000098) | 3.06580980 |
| 63 | synaptic vesicle maturation (GO:0016188) | 3.06237511 |
| 64 | cellular response to ethanol (GO:0071361) | 3.03256981 |
| 65 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.02812875 |
| 66 | pinocytosis (GO:0006907) | 3.02102050 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.01806684 |
| 68 | glycolipid catabolic process (GO:0019377) | 3.01174855 |
| 69 | regulation of macrophage chemotaxis (GO:0010758) | 2.99531086 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99451232 |
| 71 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.97346948 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 2.97157439 |
| 73 | regulation of synapse structural plasticity (GO:0051823) | 2.96160831 |
| 74 | toxin transport (GO:1901998) | 2.95886441 |
| 75 | tryptophan metabolic process (GO:0006568) | 2.95464323 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.95063521 |
| 77 | vocalization behavior (GO:0071625) | 2.93888950 |
| 78 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.93752414 |
| 79 | positive regulation of type 2 immune response (GO:0002830) | 2.92979639 |
| 80 | response to thyroid hormone (GO:0097066) | 2.92834525 |
| 81 | alanine transport (GO:0032328) | 2.91814567 |
| 82 | bile acid metabolic process (GO:0008206) | 2.91729904 |
| 83 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.89842019 |
| 84 | negative regulation of sterol transport (GO:0032372) | 2.89169474 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 2.89169474 |
| 86 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.88170260 |
| 87 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.87608415 |
| 88 | plasma lipoprotein particle remodeling (GO:0034369) | 2.86928721 |
| 89 | protein-lipid complex remodeling (GO:0034368) | 2.86928721 |
| 90 | macromolecular complex remodeling (GO:0034367) | 2.86928721 |
| 91 | regulation of podosome assembly (GO:0071801) | 2.86800509 |
| 92 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.86780995 |
| 93 | layer formation in cerebral cortex (GO:0021819) | 2.86606521 |
| 94 | positive regulation of leukocyte degranulation (GO:0043302) | 2.85955923 |
| 95 | detection of molecule of bacterial origin (GO:0032490) | 2.82817958 |
| 96 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.82189285 |
| 97 | regulation of triglyceride catabolic process (GO:0010896) | 2.80567353 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80073133 |
| 99 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.77374759 |
| 100 | positive regulation of heat generation (GO:0031652) | 2.77165436 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 2.76827252 |
| 102 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76551005 |
| 103 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76363142 |
| 104 | regulation of fever generation (GO:0031620) | 2.75764712 |
| 105 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.75230716 |
| 106 | definitive hemopoiesis (GO:0060216) | 2.74892821 |
| 107 | cholesterol efflux (GO:0033344) | 2.74775033 |
| 108 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.74079895 |
| 109 | serine family amino acid catabolic process (GO:0009071) | 2.73847401 |
| 110 | macroautophagy (GO:0016236) | 2.73179127 |
| 111 | phospholipid efflux (GO:0033700) | 2.73179027 |
| 112 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.72082713 |
| 113 | cellular modified amino acid catabolic process (GO:0042219) | 2.71302693 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.70892078 |
| 115 | acylglycerol homeostasis (GO:0055090) | 2.69789902 |
| 116 | triglyceride homeostasis (GO:0070328) | 2.69789902 |
| 117 | cellular ketone body metabolic process (GO:0046950) | 2.69763449 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.69514088 |
| 119 | positive regulation of cholesterol efflux (GO:0010875) | 2.67702698 |
| 120 | positive regulation of B cell differentiation (GO:0045579) | 2.66571277 |
| 121 | regulation of cholesterol esterification (GO:0010872) | 2.65642042 |
| 122 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.64693229 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 2.63128703 |
| 124 | positive regulation of mast cell activation (GO:0033005) | 2.62248229 |
| 125 | positive regulation of vasculogenesis (GO:2001214) | 2.61566542 |
| 126 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.61206505 |
| 127 | positive regulation of mast cell degranulation (GO:0043306) | 2.61206505 |
| 128 | glutamate secretion (GO:0014047) | 2.61102526 |
| 129 | alpha-amino acid catabolic process (GO:1901606) | 2.60368926 |
| 130 | N-acetylneuraminate metabolic process (GO:0006054) | 2.60298698 |
| 131 | fatty acid transmembrane transport (GO:1902001) | 2.60079437 |
| 132 | macrophage activation (GO:0042116) | 2.59914486 |
| 133 | proline transport (GO:0015824) | 2.59019092 |
| 134 | detection of other organism (GO:0098543) | 2.58679082 |
| 135 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 2.57797755 |
| 136 | cellular extravasation (GO:0045123) | 2.57781562 |
| 137 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.56969742 |
| 138 | regulation of gamma-delta T cell activation (GO:0046643) | 2.56619464 |
| 139 | ceramide catabolic process (GO:0046514) | 2.55885412 |
| 140 | tyrosine metabolic process (GO:0006570) | 2.55208068 |
| 141 | positive regulation of fatty acid oxidation (GO:0046321) | 2.54580195 |
| 142 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.54265885 |
| 143 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.54264041 |
| 144 | Rap protein signal transduction (GO:0032486) | 2.54144328 |
| 145 | 2-oxoglutarate metabolic process (GO:0006103) | 2.53625628 |
| 146 | amino-acid betaine metabolic process (GO:0006577) | 2.53577393 |
| 147 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.52321867 |
| 148 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.51190420 |
| 149 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.51046257 |
| 150 | negative regulation of lipase activity (GO:0060192) | 2.50950094 |
| 151 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49498199 |
| 152 | drug catabolic process (GO:0042737) | 2.49135499 |
| 153 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.48341013 |
| 154 | response to lipoprotein particle (GO:0055094) | 2.48328281 |
| 155 | B cell mediated immunity (GO:0019724) | 2.48308806 |
| 156 | neutral lipid catabolic process (GO:0046461) | 2.48034498 |
| 157 | acylglycerol catabolic process (GO:0046464) | 2.48034498 |
| 158 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.47780048 |
| 159 | amino sugar catabolic process (GO:0046348) | 2.47519473 |
| 160 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.47429098 |
| 161 | apoptotic cell clearance (GO:0043277) | 2.47393229 |
| 162 | regulation of cholesterol storage (GO:0010885) | 2.46136957 |
| 163 | regulation of lipid catabolic process (GO:0050994) | 2.44770281 |
| 164 | cellular amino acid catabolic process (GO:0009063) | 2.44091241 |
| 165 | regulation of mast cell activation (GO:0033003) | 2.44035789 |
| 166 | aromatic amino acid family metabolic process (GO:0009072) | 2.43883302 |
| 167 | acetyl-CoA metabolic process (GO:0006084) | 2.43246049 |
| 168 | complement activation (GO:0006956) | 2.43118931 |
| 169 | regulation of antigen processing and presentation (GO:0002577) | 2.42803524 |
| 170 | phagocytosis, engulfment (GO:0006911) | 2.42267327 |
| 171 | response to nerve growth factor (GO:1990089) | 2.42021091 |
| 172 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.42021091 |
| 173 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.41627073 |
| 174 | gamma-aminobutyric acid transport (GO:0015812) | 2.41397713 |
| 175 | activation of protein kinase A activity (GO:0034199) | 2.40708373 |
| 176 | regulation of regulated secretory pathway (GO:1903305) | 2.40618684 |
| 177 | arginine metabolic process (GO:0006525) | 2.39586741 |
| 178 | cellular hyperosmotic response (GO:0071474) | 2.39429388 |
| 179 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.39337846 |
| 180 | response to host immune response (GO:0052572) | 2.39337846 |
| 181 | positive regulation of interferon-alpha production (GO:0032727) | 2.37617298 |
| 182 | estrogen biosynthetic process (GO:0006703) | 2.37280093 |
| 183 | lipoprotein transport (GO:0042953) | 2.37094866 |
| 184 | mannose metabolic process (GO:0006013) | 2.36994325 |
| 185 | positive regulation of antigen processing and presentation (GO:0002579) | 2.36911829 |
| 186 | dendritic spine morphogenesis (GO:0060997) | 2.36367848 |
| 187 | neurotransmitter secretion (GO:0007269) | 2.36071017 |
| 188 | exploration behavior (GO:0035640) | 2.35799230 |
| 189 | detection of external biotic stimulus (GO:0098581) | 2.35226280 |
| 190 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.34819831 |
| 191 | endothelium development (GO:0003158) | 2.34784455 |
| 192 | surfactant homeostasis (GO:0043129) | 2.34779335 |
| 193 | barbed-end actin filament capping (GO:0051016) | 2.34314007 |
| 194 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.33716910 |
| 195 | negative regulation of granulocyte differentiation (GO:0030853) | 2.33465130 |
| 196 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.32305619 |
| 197 | negative regulation of sodium ion transport (GO:0010766) | 2.31783871 |
| 198 | lysosome organization (GO:0007040) | 2.30899413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.91640914 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.04334899 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.64563628 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63399612 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.43652129 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.28998719 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.27540632 |
| 8 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13659464 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09568779 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00225138 |
| 11 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.98543930 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.90328814 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66522199 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.64721329 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62121844 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.57770490 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.53731509 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.41868266 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40708244 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34888308 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19936532 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12895997 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06269933 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02934630 |
| 25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.86542802 |
| 26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.86542802 |
| 27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.86542802 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.86012703 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85838055 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.84406257 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.80630803 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77034839 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75489090 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75398000 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.73561593 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.73031393 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72551843 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72551843 |
| 39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.72071240 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70728036 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69239275 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68375683 |
| 43 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.68361207 |
| 44 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.68153796 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.67153459 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.65475532 |
| 47 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.65176379 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.64742913 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64646687 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58708893 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.58698513 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57583324 |
| 53 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.54676270 |
| 54 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52622137 |
| 55 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49866222 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48645157 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48452480 |
| 58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48040651 |
| 59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.43584359 |
| 60 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41962252 |
| 61 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39129449 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38731214 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35812077 |
| 64 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35654182 |
| 65 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34640281 |
| 66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34192051 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32916931 |
| 68 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32390429 |
| 69 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31206551 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31205332 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31034719 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30526200 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30046616 |
| 74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28722921 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27641923 |
| 76 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27557880 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27270197 |
| 78 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27269881 |
| 79 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.27227042 |
| 80 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.27095139 |
| 81 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26211219 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.26137165 |
| 83 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24994471 |
| 84 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24422500 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23673041 |
| 86 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23518615 |
| 87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22618355 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20150311 |
| 89 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19438629 |
| 90 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.19106818 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16525333 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15097066 |
| 93 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.14152511 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13901917 |
| 95 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13801732 |
| 96 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11928381 |
| 97 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11768459 |
| 98 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11768459 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09256426 |
| 100 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08684348 |
| 101 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08560383 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07637280 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06317377 |
| 104 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05390041 |
| 105 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04490564 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04237411 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03305396 |
| 108 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03280037 |
| 109 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02245604 |
| 110 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02140798 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01999497 |
| 112 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01996252 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01037621 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00288608 |
| 115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99619458 |
| 116 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99464470 |
| 117 | * AR_19668381_ChIP-Seq_PC3_Human | 0.99226029 |
| 118 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99012937 |
| 119 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97904898 |
| 120 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97823210 |
| 121 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97667872 |
| 122 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97627550 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96339474 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96307375 |
| 125 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95850986 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95067487 |
| 127 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94988102 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94891525 |
| 129 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94714512 |
| 130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94464002 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92970591 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92413207 |
| 133 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91683259 |
| 134 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91486926 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91352287 |
| 136 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90228482 |
| 137 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89816716 |
| 138 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89295388 |
| 139 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88844203 |
| 140 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88668176 |
| 141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88655732 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87972364 |
| 143 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86912509 |
| 144 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86794250 |
| 145 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.86230529 |
| 146 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86212222 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85969716 |
| 148 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.85554214 |
| 149 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84938073 |
| 150 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83808925 |
| 151 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83134994 |
| 152 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83087768 |
| 153 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82832906 |
| 154 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82250521 |
| 155 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82021433 |
| 156 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81657717 |
| 157 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81038136 |
| 158 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80142830 |
| 159 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.79901032 |
| 160 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79553774 |
| 161 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79458716 |
| 162 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.79327478 |
| 163 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79186536 |
| 164 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78490526 |
| 165 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78142626 |
| 166 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.76891257 |
| 167 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75619486 |
| 168 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.74878740 |
| 169 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.74698130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.43555057 |
| 2 | MP0005360_urolithiasis | 4.49909616 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.15084173 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.11146019 |
| 5 | MP0005365_abnormal_bile_salt | 4.08634316 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.60907949 |
| 7 | MP0010329_abnormal_lipoprotein_level | 2.94446131 |
| 8 | MP0003724_increased_susceptibility_to | 2.90103596 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.88514167 |
| 10 | MP0003252_abnormal_bile_duct | 2.63707533 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.57988427 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.57988427 |
| 13 | MP0009278_abnormal_bone_marrow | 2.55096455 |
| 14 | MP0005083_abnormal_biliary_tract | 2.54599051 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.47121779 |
| 16 | MP0003436_decreased_susceptibility_to | 2.44193325 |
| 17 | MP0002822_catalepsy | 2.41989754 |
| 18 | MP0006082_CNS_inflammation | 2.38751308 |
| 19 | MP0002419_abnormal_innate_immunity | 2.35267582 |
| 20 | MP0004858_abnormal_nervous_system | 2.28155962 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.22809563 |
| 22 | * MP0003635_abnormal_synaptic_transmissio | 2.14156356 |
| 23 | MP0008004_abnormal_stomach_pH | 2.13079991 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.06373829 |
| 25 | MP0005387_immune_system_phenotype | 2.04101057 |
| 26 | MP0001790_abnormal_immune_system | 2.04101057 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.01318399 |
| 28 | MP0009840_abnormal_foam_cell | 2.00053718 |
| 29 | MP0004130_abnormal_muscle_cell | 1.98851978 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.96335124 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.92585268 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.92136017 |
| 33 | MP0009785_altered_susceptibility_to | 1.90687680 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.87678511 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.87454595 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.84651436 |
| 37 | MP0003329_amyloid_beta_deposits | 1.84006445 |
| 38 | MP0004270_analgesia | 1.82735354 |
| 39 | MP0000604_amyloidosis | 1.81357149 |
| 40 | MP0005025_abnormal_response_to | 1.75830635 |
| 41 | MP0002118_abnormal_lipid_homeostasis | 1.74098695 |
| 42 | MP0006054_spinal_hemorrhage | 1.71651847 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.70764343 |
| 44 | MP0005332_abnormal_amino_acid | 1.69184168 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.65595392 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.65500347 |
| 47 | MP0009745_abnormal_behavioral_response | 1.62462765 |
| 48 | MP0003195_calcinosis | 1.61006843 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.55928612 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.54937321 |
| 51 | MP0000685_abnormal_immune_system | 1.54743401 |
| 52 | MP0005647_abnormal_sex_gland | 1.52844027 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.52023611 |
| 54 | MP0004947_skin_inflammation | 1.48843051 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.46572235 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.44808329 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.44197996 |
| 58 | MP0003828_pulmonary_edema | 1.44166334 |
| 59 | MP0009764_decreased_sensitivity_to | 1.42855837 |
| 60 | MP0000343_altered_response_to | 1.42537413 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.42306524 |
| 62 | MP0002064_seizures | 1.42115136 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.41644813 |
| 64 | * MP0003075_altered_response_to | 1.39926262 |
| 65 | MP0000609_abnormal_liver_physiology | 1.37544518 |
| 66 | MP0002723_abnormal_immune_serum | 1.35230911 |
| 67 | MP0003880_abnormal_central_pattern | 1.33765733 |
| 68 | MP0001853_heart_inflammation | 1.32727250 |
| 69 | MP0003690_abnormal_glial_cell | 1.30017785 |
| 70 | MP0005671_abnormal_response_to | 1.29455752 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.29347667 |
| 72 | MP0003091_abnormal_cell_migration | 1.29195607 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.28174954 |
| 74 | MP0002405_respiratory_system_inflammati | 1.26829399 |
| 75 | MP0005535_abnormal_body_temperature | 1.26422200 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 1.26344477 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 1.25809134 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.20795526 |
| 79 | MP0001501_abnormal_sleep_pattern | 1.19925223 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 1.17542413 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 1.17326975 |
| 82 | MP0008469_abnormal_protein_level | 1.16568932 |
| 83 | MP0001819_abnormal_immune_cell | 1.16295846 |
| 84 | MP0000920_abnormal_myelination | 1.15608315 |
| 85 | MP0001800_abnormal_humoral_immune | 1.15146929 |
| 86 | MP0001968_abnormal_touch/_nociception | 1.14600452 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.14027584 |
| 88 | MP0004510_myositis | 1.13816301 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13268516 |
| 90 | MP0003448_altered_tumor_morphology | 1.08621754 |
| 91 | MP0003868_abnormal_feces_composition | 1.08078017 |
| 92 | MP0002254_reproductive_system_inflammat | 1.07150566 |
| 93 | MP0005248_abnormal_Harderian_gland | 1.03772547 |
| 94 | MP0003183_abnormal_peptide_metabolism | 1.03354418 |
| 95 | MP0002733_abnormal_thermal_nociception | 1.03268716 |
| 96 | MP0005058_abnormal_lysosome_morphology | 1.01234835 |
| 97 | MP0005670_abnormal_white_adipose | 1.01042692 |
| 98 | MP0003303_peritoneal_inflammation | 1.00361381 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.99658917 |
| 100 | MP0001177_atelectasis | 0.99159531 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.99065869 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.98838458 |
| 103 | MP0003633_abnormal_nervous_system | 0.98512066 |
| 104 | MP0005595_abnormal_vascular_smooth | 0.98390638 |
| 105 | * MP0004811_abnormal_neuron_physiology | 0.98019842 |
| 106 | MP0005451_abnormal_body_composition | 0.97818601 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.97030164 |
| 108 | MP0005310_abnormal_salivary_gland | 0.92392534 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.92184574 |
| 110 | MP0003879_abnormal_hair_cell | 0.90844129 |
| 111 | MP0002734_abnormal_mechanical_nocicepti | 0.89813222 |
| 112 | MP0004885_abnormal_endolymph | 0.89434829 |
| 113 | MP0005334_abnormal_fat_pad | 0.88835838 |
| 114 | MP0000383_abnormal_hair_follicle | 0.88561972 |
| 115 | MP0008874_decreased_physiological_sensi | 0.88554023 |
| 116 | MP0002735_abnormal_chemical_nociception | 0.88378347 |
| 117 | MP0001915_intracranial_hemorrhage | 0.86973186 |
| 118 | MP0001486_abnormal_startle_reflex | 0.86897199 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.86520265 |
| 120 | MP0000778_abnormal_nervous_system | 0.85551611 |
| 121 | MP0010386_abnormal_urinary_bladder | 0.84859285 |
| 122 | MP0009046_muscle_twitch | 0.84497501 |
| 123 | MP0005448_abnormal_energy_balance | 0.84372021 |
| 124 | MP0000716_abnormal_immune_system | 0.84266499 |
| 125 | MP0010307_abnormal_tumor_latency | 0.83913787 |
| 126 | MP0003283_abnormal_digestive_organ | 0.82429318 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.82275927 |
| 128 | MP0003632_abnormal_nervous_system | 0.81993916 |
| 129 | MP0003634_abnormal_glial_cell | 0.81916428 |
| 130 | MP0005187_abnormal_penis_morphology | 0.81441666 |
| 131 | MP0001756_abnormal_urination | 0.79675030 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.79628088 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.79134465 |
| 134 | MP0001440_abnormal_grooming_behavior | 0.78186237 |
| 135 | MP0002090_abnormal_vision | 0.76216680 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.75588956 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.75153767 |
| 138 | MP0010678_abnormal_skin_adnexa | 0.74726223 |
| 139 | MP0005386_behavior/neurological_phenoty | 0.74329567 |
| 140 | MP0004924_abnormal_behavior | 0.74329567 |
| 141 | MP0005076_abnormal_cell_differentiation | 0.73942193 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.73054710 |
| 143 | MP0002736_abnormal_nociception_after | 0.73043496 |
| 144 | MP0002557_abnormal_social/conspecific_i | 0.72909365 |
| 145 | MP0000689_abnormal_spleen_morphology | 0.72365554 |
| 146 | MP0003631_nervous_system_phenotype | 0.71429623 |
| 147 | MP0002971_abnormal_brown_adipose | 0.70011230 |
| 148 | MP0009643_abnormal_urine_homeostasis | 0.69575005 |
| 149 | MP0000955_abnormal_spinal_cord | 0.69408528 |
| 150 | MP0009763_increased_sensitivity_to | 0.68928351 |
| 151 | MP0002272_abnormal_nervous_system | 0.68842490 |
| 152 | MP0000371_diluted_coat_color | 0.67906140 |
| 153 | MP0002398_abnormal_bone_marrow | 0.67531880 |
| 154 | MP0002133_abnormal_respiratory_system | 0.67405239 |
| 155 | MP0005388_respiratory_system_phenotype | 0.67405239 |
| 156 | * MP0005166_decreased_susceptibility_to | 0.67366883 |
| 157 | MP0002184_abnormal_innervation | 0.67005668 |
| 158 | MP0001970_abnormal_pain_threshold | 0.66929672 |
| 159 | MP0005164_abnormal_response_to | 0.66012221 |
| 160 | MP0003953_abnormal_hormone_level | 0.64949720 |
| 161 | MP0001881_abnormal_mammary_gland | 0.64309968 |
| 162 | MP0003795_abnormal_bone_structure | 0.64151785 |
| 163 | MP0004883_abnormal_blood_vessel | 0.63828420 |
| 164 | MP0009765_abnormal_xenobiotic_induced | 0.63580081 |
| 165 | MP0005423_abnormal_somatic_nervous | 0.63337603 |
| 166 | MP0006276_abnormal_autonomic_nervous | 0.61983983 |
| 167 | MP0001984_abnormal_olfaction | 0.61616552 |
| 168 | MP0002429_abnormal_blood_cell | 0.61066725 |
| 169 | MP0004185_abnormal_adipocyte_glucose | 0.60966209 |
| 170 | MP0003941_abnormal_skin_development | 0.60802433 |
| 171 | MP0005375_adipose_tissue_phenotype | 0.60687095 |
| 172 | MP0001851_eye_inflammation | 0.60376006 |
| 173 | MP0009115_abnormal_fat_cell | 0.60118431 |
| 174 | MP0005409_darkened_coat_color | 0.59460690 |
| 175 | MP0005390_skeleton_phenotype | 0.59330939 |
| 176 | MP0005165_increased_susceptibility_to | 0.57551780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.05521584 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.05521584 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.05521584 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.18578632 |
| 5 | Complement deficiency (HP:0004431) | 4.51039744 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 4.42297179 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.28550337 |
| 8 | Disinhibition (HP:0000734) | 4.20884734 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.88083507 |
| 10 | Xanthomatosis (HP:0000991) | 3.84300055 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.80236756 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.78716344 |
| 13 | Loss of speech (HP:0002371) | 3.75642101 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.69465628 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.69199091 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.52275765 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.51554343 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.41053080 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.40439786 |
| 20 | Abnormality of complement system (HP:0005339) | 3.35525376 |
| 21 | Hematochezia (HP:0002573) | 3.34331226 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.29525105 |
| 23 | Mutism (HP:0002300) | 3.28986548 |
| 24 | Epidermoid cyst (HP:0200040) | 3.27113086 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.26792699 |
| 26 | Myokymia (HP:0002411) | 3.21030056 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 3.02039893 |
| 28 | Joint hemorrhage (HP:0005261) | 2.98709735 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 2.96350014 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 2.93796201 |
| 31 | Abnormality of the lower motor neuron (HP:0002366) | 2.91451955 |
| 32 | Ketosis (HP:0001946) | 2.89999883 |
| 33 | Turricephaly (HP:0000262) | 2.89549595 |
| 34 | Inappropriate behavior (HP:0000719) | 2.84799345 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 2.84626329 |
| 36 | Apathy (HP:0000741) | 2.80478922 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66164720 |
| 38 | Diminished motivation (HP:0000745) | 2.65844045 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.65574572 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.61497240 |
| 41 | Abnormality of the periventricular white matter (HP:0002518) | 2.60438435 |
| 42 | Abnormality of the lumbar spine (HP:0100712) | 2.59267843 |
| 43 | Ketoacidosis (HP:0001993) | 2.58590678 |
| 44 | Focal motor seizures (HP:0011153) | 2.56643920 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.56414663 |
| 46 | Thoracic kyphosis (HP:0002942) | 2.56150723 |
| 47 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.55702890 |
| 48 | Skin nodule (HP:0200036) | 2.55369321 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 2.54883592 |
| 50 | Focal seizures (HP:0007359) | 2.54322343 |
| 51 | Torticollis (HP:0000473) | 2.53116280 |
| 52 | Hyperglycinemia (HP:0002154) | 2.50198159 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.48958852 |
| 54 | Gout (HP:0001997) | 2.48653477 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.48212255 |
| 56 | Hyperammonemia (HP:0001987) | 2.47531058 |
| 57 | Glomerulonephritis (HP:0000099) | 2.44783241 |
| 58 | Hypolipoproteinemia (HP:0010981) | 2.42949686 |
| 59 | Neurofibrillary tangles (HP:0002185) | 2.41484247 |
| 60 | Hyperglycinuria (HP:0003108) | 2.37973671 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36216322 |
| 62 | Orchitis (HP:0100796) | 2.35953499 |
| 63 | Neuronal loss in central nervous system (HP:0002529) | 2.35403692 |
| 64 | Supranuclear gaze palsy (HP:0000605) | 2.35173432 |
| 65 | Nuclear cataract (HP:0100018) | 2.32810421 |
| 66 | Agnosia (HP:0010524) | 2.32506216 |
| 67 | Esophageal varix (HP:0002040) | 2.29483777 |
| 68 | Increased CSF protein (HP:0002922) | 2.28156928 |
| 69 | Amyloidosis (HP:0011034) | 2.27607451 |
| 70 | Myositis (HP:0100614) | 2.26063555 |
| 71 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.25179502 |
| 72 | Focal dystonia (HP:0004373) | 2.24928752 |
| 73 | Action tremor (HP:0002345) | 2.24391401 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.23067163 |
| 75 | Optic neuritis (HP:0100653) | 2.23067163 |
| 76 | Thoracolumbar scoliosis (HP:0002944) | 2.21449598 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21142452 |
| 78 | Craniofacial dystonia (HP:0012179) | 2.20585485 |
| 79 | Status epilepticus (HP:0002133) | 2.20381331 |
| 80 | Mitral stenosis (HP:0001718) | 2.19741825 |
| 81 | Hypoglycemic coma (HP:0001325) | 2.19221122 |
| 82 | Retinal atrophy (HP:0001105) | 2.18493675 |
| 83 | Abnormality of glycine metabolism (HP:0010895) | 2.13970810 |
| 84 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13970810 |
| 85 | Gingivitis (HP:0000230) | 2.13942873 |
| 86 | Lymphangioma (HP:0100764) | 2.12758094 |
| 87 | Visual hallucinations (HP:0002367) | 2.10546285 |
| 88 | Impaired social interactions (HP:0000735) | 2.09880493 |
| 89 | Abnormal social behavior (HP:0012433) | 2.09880493 |
| 90 | Progressive visual loss (HP:0000529) | 2.08152069 |
| 91 | Long toe (HP:0010511) | 2.06614811 |
| 92 | Recurrent skin infections (HP:0001581) | 2.06520327 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.04751805 |
| 94 | Neonatal onset (HP:0003623) | 2.04544586 |
| 95 | Abnormality of the intrinsic pathway (HP:0010989) | 2.03314348 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 2.02956587 |
| 97 | Nephritis (HP:0000123) | 2.02774666 |
| 98 | Spontaneous abortion (HP:0005268) | 2.02258698 |
| 99 | Stroke (HP:0001297) | 2.00050338 |
| 100 | Peripheral demyelination (HP:0011096) | 1.99027250 |
| 101 | Hepatocellular carcinoma (HP:0001402) | 1.97667296 |
| 102 | Postural instability (HP:0002172) | 1.97601420 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 1.97600592 |
| 104 | Spastic diplegia (HP:0001264) | 1.96629819 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96534602 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 1.96475816 |
| 107 | Abnormality of the fingertips (HP:0001211) | 1.96283274 |
| 108 | Myocardial infarction (HP:0001658) | 1.88213376 |
| 109 | Bronchomalacia (HP:0002780) | 1.87419211 |
| 110 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85780337 |
| 111 | Hemorrhage of the eye (HP:0011885) | 1.84445828 |
| 112 | Global brain atrophy (HP:0002283) | 1.83929135 |
| 113 | Hypoglycemic seizures (HP:0002173) | 1.83899557 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 1.83305008 |
| 115 | Depression (HP:0000716) | 1.83249301 |
| 116 | Poor eye contact (HP:0000817) | 1.82828394 |
| 117 | Purpura (HP:0000979) | 1.82654149 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.82431201 |
| 119 | Generalized tonic-clonic seizures (HP:0002069) | 1.81238373 |
| 120 | Fat malabsorption (HP:0002630) | 1.80178091 |
| 121 | Resting tremor (HP:0002322) | 1.79039472 |
| 122 | Gingival bleeding (HP:0000225) | 1.78891897 |
| 123 | Acute lymphatic leukemia (HP:0006721) | 1.78666772 |
| 124 | Excessive salivation (HP:0003781) | 1.77857032 |
| 125 | Drooling (HP:0002307) | 1.77857032 |
| 126 | Protruding tongue (HP:0010808) | 1.77343132 |
| 127 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.77025390 |
| 128 | Recurrent fungal infections (HP:0002841) | 1.76109597 |
| 129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.75625411 |
| 130 | Cortical dysplasia (HP:0002539) | 1.74986600 |
| 131 | Hepatoblastoma (HP:0002884) | 1.74723926 |
| 132 | Death in childhood (HP:0003819) | 1.74297953 |
| 133 | Stomatitis (HP:0010280) | 1.73712098 |
| 134 | Xerostomia (HP:0000217) | 1.73120863 |
| 135 | Shallow orbits (HP:0000586) | 1.72806389 |
| 136 | Pulmonary infiltrates (HP:0002113) | 1.72693995 |
| 137 | Abnormality of nucleobase metabolism (HP:0010932) | 1.72651438 |
| 138 | Striae distensae (HP:0001065) | 1.72578379 |
| 139 | Personality changes (HP:0000751) | 1.72544464 |
| 140 | Thickened calvaria (HP:0002684) | 1.72094311 |
| 141 | Urinary incontinence (HP:0000020) | 1.71045697 |
| 142 | Basal ganglia calcification (HP:0002135) | 1.70998689 |
| 143 | Hemoptysis (HP:0002105) | 1.70877732 |
| 144 | Hepatosplenomegaly (HP:0001433) | 1.70566857 |
| 145 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.69995028 |
| 146 | Dementia (HP:0000726) | 1.69740068 |
| 147 | Hyperventilation (HP:0002883) | 1.69588010 |
| 148 | Mucopolysacchariduria (HP:0008155) | 1.68849465 |
| 149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68849465 |
| 150 | Amaurosis fugax (HP:0100576) | 1.68615921 |
| 151 | Cerebral aneurysm (HP:0004944) | 1.67994124 |
| 152 | Abnormality of the thoracic spine (HP:0100711) | 1.67148509 |
| 153 | Absence seizures (HP:0002121) | 1.66363868 |
| 154 | Pathologic fracture (HP:0002756) | 1.65797867 |
| 155 | Hydroxyprolinuria (HP:0003080) | 1.65457521 |
| 156 | Abnormality of proline metabolism (HP:0010907) | 1.65457521 |
| 157 | Polygenic inheritance (HP:0010982) | 1.64892471 |
| 158 | Cellulitis (HP:0100658) | 1.64636048 |
| 159 | Upper limb amyotrophy (HP:0009129) | 1.64460383 |
| 160 | Distal upper limb amyotrophy (HP:0007149) | 1.64460383 |
| 161 | Keratoconjunctivitis (HP:0001096) | 1.63913746 |
| 162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63780778 |
| 163 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63780778 |
| 164 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63780778 |
| 165 | Hypsarrhythmia (HP:0002521) | 1.61573593 |
| 166 | EEG with generalized epileptiform discharges (HP:0011198) | 1.61293538 |
| 167 | Epileptiform EEG discharges (HP:0011182) | 1.61012213 |
| 168 | Epistaxis (HP:0000421) | 1.60851829 |
| 169 | Increased serum ferritin (HP:0003281) | 1.60520028 |
| 170 | Abnormality of iron homeostasis (HP:0011031) | 1.59800929 |
| 171 | Asymmetric septal hypertrophy (HP:0001670) | 1.59003106 |
| 172 | Portal hypertension (HP:0001409) | 1.58800165 |
| 173 | Premature loss of primary teeth (HP:0006323) | 1.58083379 |
| 174 | Recurrent viral infections (HP:0004429) | 1.57343542 |
| 175 | Acrocyanosis (HP:0001063) | 1.56289843 |
| 176 | Vertigo (HP:0002321) | 1.56266094 |
| 177 | Progressive neurologic deterioration (HP:0002344) | 1.55844285 |
| 178 | Papillary thyroid carcinoma (HP:0002895) | 1.54752809 |
| 179 | Thrombocytosis (HP:0001894) | 1.52403914 |
| 180 | Vasculitis (HP:0002633) | 1.50875570 |
| 181 | Thrombophlebitis (HP:0004418) | 1.50509225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.51362000 |
| 2 | MATK | 3.26394706 |
| 3 | NTRK3 | 3.04352908 |
| 4 | MAP3K9 | 2.87990398 |
| 5 | MARK1 | 2.72925145 |
| 6 | TRIB3 | 2.62654282 |
| 7 | MAP3K14 | 2.58344965 |
| 8 | BLK | 2.40555453 |
| 9 | KSR2 | 2.35849451 |
| 10 | RIPK1 | 2.31215385 |
| 11 | SIK1 | 2.26298015 |
| 12 | RIPK4 | 2.04847983 |
| 13 | PKN2 | 2.04198870 |
| 14 | MAP3K4 | 2.01392989 |
| 15 | TBK1 | 1.96966417 |
| 16 | MAP2K4 | 1.87597776 |
| 17 | PRKD3 | 1.86174638 |
| 18 | IRAK3 | 1.84597899 |
| 19 | CAMKK1 | 1.82734781 |
| 20 | NTRK1 | 1.81610853 |
| 21 | MINK1 | 1.79808978 |
| 22 | TYK2 | 1.79479501 |
| 23 | MAP3K2 | 1.78134542 |
| 24 | * DAPK2 | 1.76005973 |
| 25 | CAMK1D | 1.75130136 |
| 26 | CAMK1G | 1.72971055 |
| 27 | TGFBR2 | 1.71235563 |
| 28 | PAK6 | 1.69985984 |
| 29 | SIK2 | 1.55831343 |
| 30 | KIT | 1.55774505 |
| 31 | CSF1R | 1.55014943 |
| 32 | GRK7 | 1.54777974 |
| 33 | INSRR | 1.52507545 |
| 34 | BCKDK | 1.49828920 |
| 35 | ERN1 | 1.48480459 |
| 36 | KSR1 | 1.47741210 |
| 37 | CSK | 1.47460963 |
| 38 | BRD4 | 1.46783566 |
| 39 | MAP3K6 | 1.45457017 |
| 40 | RET | 1.43932231 |
| 41 | ACVR1B | 1.43343233 |
| 42 | LATS2 | 1.42819380 |
| 43 | CDC42BPA | 1.39171713 |
| 44 | STK38 | 1.37029135 |
| 45 | JAK3 | 1.34552716 |
| 46 | NTRK2 | 1.29874549 |
| 47 | MAP4K1 | 1.29766910 |
| 48 | MAP2K3 | 1.27222526 |
| 49 | SGK3 | 1.26252377 |
| 50 | FGFR4 | 1.25228063 |
| 51 | TNIK | 1.24600189 |
| 52 | PDGFRA | 1.23634631 |
| 53 | TIE1 | 1.23061239 |
| 54 | YES1 | 1.19114600 |
| 55 | EPHA3 | 1.18756955 |
| 56 | IRAK4 | 1.16670390 |
| 57 | IKBKE | 1.15795375 |
| 58 | PTK6 | 1.08853627 |
| 59 | CDK5 | 1.08694851 |
| 60 | SGK2 | 1.07656654 |
| 61 | MAP3K5 | 1.06944842 |
| 62 | TAOK1 | 1.06561103 |
| 63 | MAP3K3 | 1.06283802 |
| 64 | MAP3K7 | 1.05837893 |
| 65 | MAP2K7 | 1.05041773 |
| 66 | IKBKB | 1.04596605 |
| 67 | MKNK1 | 1.04059053 |
| 68 | FER | 1.02001374 |
| 69 | FGFR2 | 0.97504425 |
| 70 | LMTK2 | 0.96845744 |
| 71 | PRKCH | 0.94769750 |
| 72 | ERBB2 | 0.93998329 |
| 73 | MST1R | 0.92673989 |
| 74 | PRKCZ | 0.90713404 |
| 75 | TAOK2 | 0.90638082 |
| 76 | SGK223 | 0.88602528 |
| 77 | SGK494 | 0.88602528 |
| 78 | STK38L | 0.88494369 |
| 79 | SYK | 0.87437674 |
| 80 | MAPK7 | 0.87408196 |
| 81 | IRAK2 | 0.87331694 |
| 82 | LYN | 0.86769024 |
| 83 | HIPK2 | 0.85853428 |
| 84 | CDK12 | 0.85591524 |
| 85 | PRKG2 | 0.85204782 |
| 86 | MAP3K1 | 0.85074980 |
| 87 | MAP3K13 | 0.84473216 |
| 88 | PTK2 | 0.83002916 |
| 89 | IRAK1 | 0.82763736 |
| 90 | ZAP70 | 0.82133007 |
| 91 | TAF1 | 0.81604510 |
| 92 | PTK2B | 0.79211000 |
| 93 | TAOK3 | 0.79183899 |
| 94 | JAK2 | 0.78825776 |
| 95 | FES | 0.78610716 |
| 96 | HCK | 0.78469834 |
| 97 | PDPK1 | 0.78435230 |
| 98 | EPHB2 | 0.77147305 |
| 99 | PRKCG | 0.76514175 |
| 100 | ERBB4 | 0.76033842 |
| 101 | PHKG2 | 0.74859630 |
| 102 | PHKG1 | 0.74859630 |
| 103 | TYRO3 | 0.74443908 |
| 104 | GRK5 | 0.74412592 |
| 105 | DDR2 | 0.72937911 |
| 106 | BMPR2 | 0.70312036 |
| 107 | TEC | 0.70190121 |
| 108 | MAP2K1 | 0.70185197 |
| 109 | CAMK4 | 0.69669603 |
| 110 | BMX | 0.68902893 |
| 111 | PRKD2 | 0.68776797 |
| 112 | SCYL2 | 0.67091684 |
| 113 | PDGFRB | 0.67046177 |
| 114 | PAK3 | 0.65112538 |
| 115 | LATS1 | 0.65106968 |
| 116 | ICK | 0.64780382 |
| 117 | CHUK | 0.64086894 |
| 118 | STK11 | 0.63102677 |
| 119 | SGK1 | 0.62311698 |
| 120 | PDK1 | 0.61466149 |
| 121 | JAK1 | 0.60238922 |
| 122 | FGFR3 | 0.59968822 |
| 123 | NME2 | 0.58025424 |
| 124 | LCK | 0.56525800 |
| 125 | CAMK1 | 0.55029046 |
| 126 | ALK | 0.54668589 |
| 127 | FGR | 0.53033977 |
| 128 | WNK3 | 0.52655873 |
| 129 | BTK | 0.52341469 |
| 130 | CDK6 | 0.51687084 |
| 131 | NEK1 | 0.51375233 |
| 132 | PIM1 | 0.50345592 |
| 133 | FYN | 0.49738149 |
| 134 | PRKACG | 0.49412983 |
| 135 | PINK1 | 0.49072369 |
| 136 | MARK2 | 0.48474958 |
| 137 | * RPS6KA3 | 0.47610599 |
| 138 | FGFR1 | 0.47196031 |
| 139 | CAMK2A | 0.46941695 |
| 140 | ABL1 | 0.46851376 |
| 141 | MAP3K11 | 0.45944372 |
| 142 | MTOR | 0.45650764 |
| 143 | PRKAA1 | 0.45068477 |
| 144 | TTN | 0.44267663 |
| 145 | INSR | 0.42781836 |
| 146 | DYRK1B | 0.40525655 |
| 147 | * DAPK1 | 0.40266932 |
| 148 | MAP3K10 | 0.39932037 |
| 149 | IGF1R | 0.39623977 |
| 150 | ABL2 | 0.39518913 |
| 151 | STK10 | 0.38846253 |
| 152 | EGFR | 0.38844738 |
| 153 | SRC | 0.37984433 |
| 154 | PRPF4B | 0.37833567 |
| 155 | GSK3A | 0.36358966 |
| 156 | MAPK3 | 0.36197090 |
| 157 | NEK9 | 0.35127330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.77316205 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.19424687 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.00638562 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96430600 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.67447215 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.46123073 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38468363 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.35680435 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.22036940 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21511148 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.09247329 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06627447 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.03253005 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.01845295 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87110039 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86505340 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.85407261 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83027750 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.77884917 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76391397 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.72928946 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69200654 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.66910118 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66611506 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.65724116 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64324497 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61544534 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61526135 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60154609 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59270556 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50087183 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45374192 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44626366 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43618416 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.43481984 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.42384845 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39874702 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39584518 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38742655 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33892340 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.32837261 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32781375 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31451665 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.29784303 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28815215 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.28563367 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27950787 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24067135 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20874668 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.17941155 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15214588 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14403535 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13402955 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 1.12746522 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.11669973 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11608253 |
| 57 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10667028 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09480427 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.09112397 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08602724 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07558182 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05692863 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 1.04490942 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03550498 |
| 65 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03385526 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03132559 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02764148 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01274043 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01045616 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00437939 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 1.00338835 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99106678 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.98403062 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95841175 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93866535 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93240373 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93182684 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92414966 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91860030 |
| 80 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90712519 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90681535 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.89666861 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.89202899 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89118253 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89012948 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.88941283 |
| 87 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88849625 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88205151 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.88197238 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85161644 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83251420 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.83125661 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.82729478 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82354391 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82002753 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80115241 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79788104 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.79446916 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.79168719 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.78775674 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78722364 |
| 102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77579193 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.75941058 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74290132 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74215663 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73314986 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.72653713 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72463091 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71287486 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70499170 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70278061 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70253890 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68485754 |
| 114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68475491 |
| 115 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68178004 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67753256 |
| 117 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67055785 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66465791 |
| 119 | Glioma_Homo sapiens_hsa05214 | 0.66352407 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66281127 |
| 121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.65993290 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64521746 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.63495890 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63423300 |
| 125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63005425 |
| 126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62959664 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62826028 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61852029 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.60896729 |
| 130 | Long-term depression_Homo sapiens_hsa04730 | 0.59275329 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58307163 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58188568 |
| 133 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56908486 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56901197 |
| 135 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56564752 |
| 136 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56435491 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55917256 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55809634 |
| 139 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54307557 |
| 140 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53055455 |
| 141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52461290 |
| 142 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52314762 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51779439 |
| 144 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51771774 |
| 145 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51741786 |
| 146 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49618408 |
| 147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48246777 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48197965 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47843731 |
| 150 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47359463 |
| 151 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47341326 |
| 152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47318219 |
| 153 | Adherens junction_Homo sapiens_hsa04520 | 0.47221183 |
| 154 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46814549 |
| 155 | Melanogenesis_Homo sapiens_hsa04916 | 0.46348035 |
| 156 | Apoptosis_Homo sapiens_hsa04210 | 0.45104965 |
| 157 | Gap junction_Homo sapiens_hsa04540 | 0.44812190 |
| 158 | Amoebiasis_Homo sapiens_hsa05146 | 0.44521852 |
| 159 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44482208 |
| 160 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44087204 |
| 161 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42835640 |
| 162 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41975604 |
| 163 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41016358 |
| 164 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40670641 |
| 165 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40650894 |
| 166 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39811756 |
| 167 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39769485 |
| 168 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39651033 |
| 169 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39413202 |
| 170 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39171280 |
| 171 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37561582 |
| 172 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36977698 |
| 173 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36726058 |
| 174 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36465917 |
| 175 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36343765 |
| 176 | * Bladder cancer_Homo sapiens_hsa05219 | 0.34694686 |
| 177 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34233935 |
| 178 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33774043 |
| 179 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33374139 |
| 180 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31007856 |

